Platelet aggregation inhibitor . Purpose To test the relative efficacies of aspirin and dipyridamole in the reduction of cerebral and retinal infarction or death in patients with a history of TIA. . The decision to continue or discontinue the study medications was left to the attending physician. Follow-up visits were scheduled to take place every three months beginning one month afer randomization. Median total follow-up time was 25 .
Subgroup analyses, deaths, adverse events. .
There were no differences between the two treatment groups. . Source Published report 1985. . Article Persantine Aspirin Trial in cerebral ischemia. Click on the study agent name to view status information, publications, and other trials with this agent. Copyright 1997-2001 Internet Stroke Center.